New Oral Anticoagulants in the Therapy of Antiphospholipid Syndrome

Nauchno-Prakticheskaya Revmatologiya - Russian Federation
doi 10.14412/1995-4484-2016-219-226
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IMA Press, LLC

Related search

Role of Novel Oral Anticoagulants in the Treatment of Antiphospholipid Syndrome

Hospital Pharmacy
PharmacologyPharmacy
2016English

Direct Oral Anticoagulants in Antiphospholipid Syndrome With Venous Thromboembolism: Impact of the European Medicines Agency Guidance

Research and Practice in Thrombosis and Haemostasis
2019English

Oral Surgery in Patients With Antiphospholipid Syndrome

Journal of oral science
MedicineDentistry
2019English

Novel Oral Anticoagulants for Acute Coronary Syndrome

Therapeutic Advances in Cardiovascular Disease
Cardiovascular MedicinePharmacologyCardiology
2016English

A New Generation of Oral Direct Anticoagulants

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2012English

The Use of New Oral Anticoagulants in Surgery. Part 1

Khirurgiya
MedicineSurgery
2016English

The Treatment of Venous Thromboembolism With New Oral Anticoagulants

Italian Journal of Medicine
Medicine
2013English

Direct Acting Oral Anticoagulants as Prophylaxis Against Thromboembolism in the Nephrotic Syndrome

Kidney International Reports
Nephrology
2018English

Antiphospholipid Syndrome

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy